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ROLE OF EXTRACELLULAR SIGNAL-REGULATED KINASE IN THE 
REGULATION OF ENDOTHELIUMDEPENDENT RELAXATIONS IN 
PORCINE CORONARY ARTERIES 
TL Chiu, SWS Leung 
Department of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong 
 
OBJECTIVES: Previous studies demonstrate that extracellular signal-regulated kinase 
(ERK) contributes to vascular contraction. The present study examined whether or not 
ERK modulated the different signaling pathways involved in endothelium-dependent 
relaxation. METHODS: Isolated porcine coronary arteries, with and without endothelium, 
were incubated in organ chamber for the measurement of isometric tension. They were 
contracted with U46619 (thromboxane A2 analogue, 30 to 100 nM) followed by 
cumulative additions of different relaxing agents, in the presence or absence of the ERK 
inhibitor, U0126. RESULTS: In the presence of indomethacin (cyclooxygenase inhibitor; 
10 μM), the endothelium-dependent relaxing agent bradykinin (0.1 nM to 1 μM) induced 
full relaxation, in a concentration-dependent manner, in arteries, with endothelium, 
contracted with U46619. With addition of indomethacin plus L-NAME [nitric oxide (NO) 
synthase inhibitor; 100 μM), bradykinininduced relaxation cannot be mediated via 
cyclooxygenase and NO pathways. In this condition, U0126 (10 μM) enhanced relaxation 
thus suggesting that ERK activation leads to inhibition of endothelium-dependent 
hyperpolarization (EDH) type-mediated relaxations. When EDH pathway was inhibited 
with TRAM-34 [intermediate conductance calcium-activated potassium channel (IKCa) 
blocker; 1 μM] and UCL1684 [small conductance calcium-activated potassium channel 
(SKCa) blocker; 1 μM], bradykinininduced relaxations in the presence of indomethacin 
were also potentiated by U0126, thus suggesting a possible inhibitory action of ERK on 
the NO pathway. On the other hand, U0126 did not significantly affect relaxations to 
SKA-31 (IKCa and SKCa activator; 0.1 nM to 10 μM) in arteries with endothelium. As 
such, the inhibitory action of ERK on EDH type-mediated relaxation appears to be 
upstream of IKCa and SKCa activation. In arteries without endothelium, relaxations to 
Deta NONOate (nitric oxide donor; 0.1 nM to 10 μM) and forskolin (adenylyl cyclase 
activator, 0.1 nM to 10 μM) were not affected by U0126. CONCLUSIONS: Our data 
suggest that ERK inhibits the generation of NO and EDH in the endothelium without 
affecting the signaling cascades downstream of these relaxing signals in the smooth 
muscle. Moreover, it does not play a role in the signaling cascade downstream of 
adenylyl cyclase activation in the smooth muscle. 
